tradingkey.logo
tradingkey.logo
Search

ImmunityBio Initiates Review After Receiving FDA Letter On ANKTIVA Promotional Materials

ReutersMar 24, 2026 3:28 PM

- Immunitybio Inc IBRX.O:

  • IMMUNITYBIO- ACKNOWLEDGES RECEIPT OF OPDP LETTER DATED MARCH 13, REGARDING SOME PROMOTIONAL MATERIALS FOR ANKTIVAÒ (NOGAPENDEKIN ALFA INBAKICEPT-PMLN)

  • IMMUNITYBIO- TAKE FDA’S CONCERNS SERIOUSLY AND HAVE INITIATED A REVIEW OF LETTER WITH LEGAL AND REGULATORY TEAMS

  • IMMUNITYBIO: INTEND TO RESPOND TO FDA WITHIN REQUESTED TIMEFRAME AND WORK COOPERATIVELY WITH AGENCY TO ADDRESS MATTERS RAISED IN LETTER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI